Bobo Dang

机构：Westlake University, Westlake Health Center, Institute for Advanced Study · ORCID：0000-0003-1962-8677

发表论文 57 篇 · 总被引 1219 次 · h-index 14

代表论文

• Engineered trimeric ACE2 binds viral spike protein and locks it in “Three-up” conformation to potently inhibit SARS-CoV-2 infection (2020 · Cell Research · 被引 104)
• Platform to Discover Protease-Activated Antibiotics and Application to Siderophore–Antibiotic Conjugates (2020 · Journal of the American Chemical Society · 被引 49)
• A high-throughput fully automatic biosensing platform for efficient COVID-19 detection (2022 · Biosensors and Bioelectronics · 被引 27)
• Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants (2022 · Journal of Virology · 被引 24)
• Precise control of embolic stroke with magnetized red blood cells in mice (2022 · Communications Biology · 被引 14)
• Zfp106 binds to G-quadruplex RNAs and inhibits RAN translation and formation of RNA foci caused by G4C2 repeats (2024 · Proceedings of the National Academy of Sciences · 被引 12)